Abstract
To study complement activation, we evaluated nine patients who underwent cardiac operations requiring cardiopulmonary bypass (CPB) and nine other patients who underwent thoracic vascular operations without CPB. Concentration of C3, as measured by radioimmunoassay, was used as an indicator of complement activation (C3a is a complement-degradation product).
In the CPB patients, the C3a level increased tenfold (from baseline value) after the onset of bypass, and continued to increase during bypass. Protamine produced an additional twofold increase in the C3a value, to a peak of 5461 ± 1360 ng/ml. By 12 hours after surgery, the C3a level had decreased to normal (400 ng/ml).
In the non-CPB patients, C3a remained at baseline levels until the administration of protamine, which caused a tenfold increase to a peak of 2281 ± 293 ng/ml; C3a levels returned to normal 6 hours after operation. The peak postprotamine C3a levels were significantly higher (p < 0.01) in the CPB group than in the non-CPB group. This finding was due to the fact that, during CPB, complement activation occurs via the alternative pathway; the administration of protamine then causes additional activation via the classical pathway. During thoracic vascular operations, however, complement activation occurs only in response to protamine, via the classical pathway. (Texas Heart Institute Journal 1987; 14:369-373)
Keywords: Cardiopulmonary bypass
Keywords: complement activation
Keywords: extracorporeal circulation
Keywords: protamine administration
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Best N., Sinosich M. J., Teisner B., Grudzinskas J. G., Fisher M. M. Complement activation during cardiopulmonary bypass by heparin-protamine interaction. Br J Anaesth. 1984 Apr;56(4):339–343. doi: 10.1093/bja/56.4.339. [DOI] [PubMed] [Google Scholar]
- Best N., Teisner B., Grudzinskas J. G., Fisher M. M. Classical pathway activation during an adverse response to protamine sulphate. Br J Anaesth. 1983 Nov;55(11):1149–1153. doi: 10.1093/bja/55.11.1149. [DOI] [PubMed] [Google Scholar]
- Cavarocchi N. C., Schaff H. V., Orszulak T. A., Homburger H. A., Schnell W. A., Jr, Pluth J. R. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery. 1985 Sep;98(3):525–531. [PubMed] [Google Scholar]
- Chenoweth D. E., Cooper S. W., Hugli T. E., Stewart R. W., Blackstone E. H., Kirklin J. W. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981 Feb 26;304(9):497–503. doi: 10.1056/NEJM198102263040901. [DOI] [PubMed] [Google Scholar]
- Haslam P. L., Townsend P. J., Branthwaite M. A. Complement activation during cardiopulmonary bypass. Anaesthesia. 1980 Jan;35(1):22–26. doi: 10.1111/j.1365-2044.1980.tb03715.x. [DOI] [PubMed] [Google Scholar]
- Kirklin J. K., Chenoweth D. E., Naftel D. C., Blackstone E. H., Kirklin J. W., Bitran D. D., Curd J. G., Reves J. G., Samuelson P. N. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg. 1986 Feb;41(2):193–199. doi: 10.1016/s0003-4975(10)62668-9. [DOI] [PubMed] [Google Scholar]
- Kirklin J. K., Westaby S., Blackstone E. H., Kirklin J. W., Chenoweth D. E., Pacifico A. D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983 Dec;86(6):845–857. [PubMed] [Google Scholar]
- Morel D. R., Zapol W. M., Thomas S. J., Kitain E. M., Robinson D. R., Moss J., Chenoweth D. E., Lowenstein E. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology. 1987 May;66(5):597–604. doi: 10.1097/00000542-198705000-00002. [DOI] [PubMed] [Google Scholar]